70 related articles for article (PubMed ID: 27934110)
21. SUMOylation of large tumor suppressor 1 at Lys751 attenuates its kinase activity and tumor-suppressor functions.
Mei L; Yuan L; Shi W; Fan S; Tang C; Fan X; Yang W; Qian Y; Hussain M; Wu X
Cancer Lett; 2017 Feb; 386():1-11. PubMed ID: 27847303
[TBL] [Abstract][Full Text] [Related]
22. Engineering the metal sensitive sites in Macrolampis sp2 firefly luciferase and use as a novel bioluminescent ratiometric biosensor for heavy metals.
Gabriel GV; Viviani VR
Anal Bioanal Chem; 2016 Dec; 408(30):8881-8893. PubMed ID: 27815607
[TBL] [Abstract][Full Text] [Related]
23. Mathematical Model of the Firefly Luciferase Complementation Assay Reveals a Non-Linear Relationship between the Detected Luminescence and the Affinity of the Protein Pair Being Analyzed.
Dale R; Ohmuro-Matsuyama Y; Ueda H; Kato N
PLoS One; 2016; 11(2):e0148256. PubMed ID: 26886551
[TBL] [Abstract][Full Text] [Related]
24. Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts.
Wang W; Kim SH; El-Deiry WS
Proc Natl Acad Sci U S A; 2006 Jul; 103(29):11003-8. PubMed ID: 16835297
[TBL] [Abstract][Full Text] [Related]
25. Gain-of-function mutant p53 activates small GTPase Rac1 through SUMOylation to promote tumor progression.
Yue X; Zhang C; Zhao Y; Liu J; Lin AW; Tan VM; Drake JM; Liu L; Boateng MN; Li J; Feng Z; Hu W
Genes Dev; 2017 Aug; 31(16):1641-1654. PubMed ID: 28947497
[TBL] [Abstract][Full Text] [Related]
26. Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects.
Ray P; Tsien R; Gambhir SS
Cancer Res; 2007 Apr; 67(7):3085-93. PubMed ID: 17409415
[TBL] [Abstract][Full Text] [Related]
27. In vivo effects of abolishing the single canonical sumoylation site in the C-terminal region of Drosophila p53.
Pardi N; Vámos E; Ujfaludi Z; Komonyi O; Bodai L; Boros IM
Acta Biol Hung; 2011 Dec; 62(4):397-412. PubMed ID: 22119869
[TBL] [Abstract][Full Text] [Related]
28. Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage.
Park JH; Lee SW; Yang SW; Yoo HM; Park JM; Seong MW; Ka SH; Oh KH; Jeon YJ; Chung CH
Nat Commun; 2014 Nov; 5():5483. PubMed ID: 25406032
[TBL] [Abstract][Full Text] [Related]
29. Combinatorial library screening for developing an improved split-firefly luciferase fragment-assisted complementation system for studying protein-protein interactions.
Paulmurugan R; Gambhir SS
Anal Chem; 2007 Mar; 79(6):2346-53. PubMed ID: 17295448
[TBL] [Abstract][Full Text] [Related]
30. Detection of mutant p53 using field-effect transistor biosensor.
Han SH; Kim SK; Park K; Yi SY; Park HJ; Lyu HK; Kim M; Chung BH
Anal Chim Acta; 2010 Apr; 665(1):79-83. PubMed ID: 20381694
[TBL] [Abstract][Full Text] [Related]
31. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
[TBL] [Abstract][Full Text] [Related]
32. Non-invasive imaging of firefly luciferase reporter gene expression using bioluminescence imaging in human prostate cancer models.
Li H; Li JZ; Helm GA; Pan D
Biotechnol Appl Biochem; 2007 Apr; 46(Pt 4):179-84. PubMed ID: 17073822
[TBL] [Abstract][Full Text] [Related]
33. Lable-free quadruple signal amplification strategy for sensitive electrochemical p53 gene biosensing.
Wang Z; Xia J; Song D; Zhang F; Yang M; Gui R; Xia L; Bi S; Xia Y
Biosens Bioelectron; 2016 Mar; 77():157-63. PubMed ID: 26406456
[TBL] [Abstract][Full Text] [Related]
34. Transgenic mouse model expressing P53(R172H), luciferase, EGFP, and KRAS(G12D) in a single open reading frame for live imaging of tumor.
Ju HL; Calvisi DF; Moon H; Baek S; Ribback S; Dombrowski F; Cho KJ; Chung SI; Han KH; Ro SW
Sci Rep; 2015 Jan; 5():8053. PubMed ID: 25623590
[TBL] [Abstract][Full Text] [Related]
35. Noninvasive Imaging of Ras Activity by Monomolecular Biosensor Based on Split-Luciferase Complementary Assay.
Chen L; Leng WB; Li Z; Xia HW; Ren M; Tang QL; Gong QY; Gao FB; Bi F
Sci Rep; 2017 Aug; 7(1):9945. PubMed ID: 28855513
[TBL] [Abstract][Full Text] [Related]
36. Implementation of a 220,000-compound HCS campaign to identify disruptors of the interaction between p53 and hDM2 and characterization of the confirmed hits.
Dudgeon DD; Shinde S; Hua Y; Shun TY; Lazo JS; Strock CJ; Giuliano KA; Taylor DL; Johnston PA; Johnston PA
J Biomol Screen; 2010 Aug; 15(7):766-82. PubMed ID: 20639499
[TBL] [Abstract][Full Text] [Related]
37. Interplay between nuclear transport and ubiquitin/SUMO modifications in the regulation of cancer-related proteins.
Rodríguez JA
Semin Cancer Biol; 2014 Aug; 27():11-9. PubMed ID: 24704338
[TBL] [Abstract][Full Text] [Related]
38. Over-expression of small ubiquitin-related modifier-1 and sumoylated p53 in colon cancer.
Zhang H; Kuai X; Ji Z; Li Z; Shi R
Cell Biochem Biophys; 2013; 67(3):1081-7. PubMed ID: 23640307
[TBL] [Abstract][Full Text] [Related]
39. Sensitive detection of intracellular sumoylation via SNAP tag-mediated translation and RNA polymerase-based amplification.
Yang Y; Zhang CY
Anal Chem; 2012 Feb; 84(3):1229-34. PubMed ID: 22242541
[TBL] [Abstract][Full Text] [Related]
40. Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging.
Hamstra DA; Bhojani MS; Griffin LB; Laxman B; Ross BD; Rehemtulla A
Cancer Res; 2006 Aug; 66(15):7482-9. PubMed ID: 16885345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
